Mouse Anti-Diacetoxyscripenol Monoclonal Antibody clone DAS 1mg and Diacetoxyscripenol ELISAKit 3*
Office Of Dg (ls)
Bid Publish Date
03-Feb-2026, 4:42 pm
Bid End Date
24-Feb-2026, 9:00 am
Location
Progress
Quantity
15
Category
P53 DO7
Bid Type
Single Packet Bid
Public procurement opportunity for Indian Navy P53 DO7, BCL2 READY TO USE ANTIBODY, CD 10 56C6, MONOCLONAL MOUSE ANTI HUMAN CD34, CD19 in MUMBAI, MAHARASHTRA. Quantity: 15 issued by. Submission Deadline: 24-02-2026 09: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Office Of Dg (ls)
N/a
JAMNAGAR, GUJARAT
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
Directorate Of Purchase And Stores
MUMBAI, MAHARASHTRA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | P53 DO7 | P53 DO7 | 3 | no | moic.medicalstores | 30 |
| 2 | BCL2 READY TO USE ANTIBODY | BCL2 READY TO USE ANTIBODY | 3 | no | moic.medicalstores | 30 |
| 3 | CD 10 56C6 | CD 10 56C6 | 3 | no | moic.medicalstores | 30 |
| 4 | MONOCLONAL MOUSE ANTI HUMAN CD34 | MONOCLONAL MOUSE ANTI HUMAN CD34 | 3 | no | moic.medicalstores | 30 |
| 5 | CD19 | CD19 | 3 | no | moic.medicalstores | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Indian Navy
📍 MUMBAI, MAHARASHTRA
Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)
📍 THIRUVANANTHAPURAM, KERALA
Indian Army
📍 SOUTH WEST DELHI, DELHI
Indian Air Force
📍 BANGALORE, KARNATAKA
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS